NCT07660328 Hand Function Outcome After the Application of Transfer Energy Capacitive and Resistive on Post-burn Patients Presented With Carpal Tunnel Syndrome
| NCT ID | NCT07660328 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Carpal Tunnel Syndrome (CTS) Post-burn |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2026-08-09 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2026-08-09 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Carpal Tunnel Syndrome (CTS) is a common entrapment neuropathy that can develop as a secondary complication following deep burns involving the hand or wrist. Post-burn CTS arises due to factors such as fibrosis, edema, and scar contracture, which may increase pressure on the median nerve within the carpal tunnel, leading to significant pain, sensory disturbances, and impaired hand function Recent studies support the effectiveness of Transfer Energy Capacitive and Resistive (TECAR ) therapy in idiopathic CTS, showing improvements in pain, symptom severity, and function, as measured by validated tools such as the Boston Carpal Tunnel Questionnaire (BCTQ) and Visual Analogue Scale (VAS). A study reported that both TECAR and ultrasound groups showed significant symptom improvement after treatment, although ultrasound had more sustained effects on median nerve cross-sectional area at 3 months
Eligibility Criteria
Inclusion Criteria: * Participant is between 20 and 40 years of age. * Diagnosed with mild to moderate carpal tunnel syndrome (CTS). * History of an upper limb burn, with the percentage of the Total Body Surface Area (TBSA) ranging from 20% to 25%. * Upper limb burn is diagnosed as a 2nd or 3rd-degree burn complicated with carpal tunnel syndrome. * Carpal tunnel syndrome diagnosis is clinically confirmed using physical examination, including a positive Tinel's sign and positive Phalen's test. * Participant provides written informed consent before enrollment. Exclusion Criteria: * History of double crush syndrome, cervical radiculopathy, or fibromyalgia. * History of wrist fracture or distal radius fracture. * Diagnosis of systemic or local diseases that contribute to peripheral neuropathy, including Diabetes Mellitus or rheumatoid arthritis (RA). * Diagnosis of hypothyroidism, skin diseases, or peripheral vascular diseases. * Current or past history of cancer. * Use of a hand or wrist splint within the past three months. * Presence of an implanted pacemaker or electrical prosthesis.
Contact & Investigator
Wafaa Hussien Borhan, Professor
STUDY DIRECTOR
Cairo University
Frequently Asked Questions
Who can join the NCT07660328 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Carpal Tunnel Syndrome (CTS) Post-burn. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07660328 currently recruiting?
Yes, NCT07660328 is actively recruiting participants. Contact the research team at pt.ahmed.mido@gmail.com for enrollment information.
Where is the NCT07660328 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT07660328 clinical trial?
NCT07660328 is sponsored by Cairo University. The principal investigator is Wafaa Hussien Borhan, Professor at Cairo University. The trial plans to enroll 52 participants.